| PERIOD ENDING | 29-Mar-09 | 28-Dec-08 | 28-Sep-08 | 29-Jun-08 | | Total Revenue | 863,984 | 896,522 | 310,371 | 313,014 | | Cost of Revenue | 675,942 | 759,891 | 222,206 | 220,527 | | | Gross Profit | 188,042 | 136,631 | 88,165 | 92,487 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 111,405 | 63,589 | 53,749 | 66,587 | | Non Recurring | 11,041 | 482,866 | (82) | (41) | | Others | 51,662 | 23,928 | 30,701 | 17,693 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,934 | (433,752) | 3,797 | 8,248 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,518) | (21,477) | (314) | (7,975) | | Earnings Before Interest And Taxes | 6,416 | (455,229) | 3,483 | 273 | | Interest Expense | 22,149 | 25,989 | 13,585 | 13,944 | | Income Before Tax | (15,733) | (481,218) | (10,102) | (13,671) | | Income Tax Expense | (4,809) | (87,002) | 2,938 | (6,766) | | Minority Interest |
-
|
-
| (326) |
-
| | | | Net Income From Continuing Ops | (10,924) | (394,216) | (13,366) | (6,905) | | | Non-recurring Events | | Discontinued Operations |
-
| 998 | 1,219 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,924) | (393,218) | (12,147) | (6,905) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,924) | ($393,218) | ($12,147) | ($6,905) |
|
0.45% Nasdaq 
0.20%
Income Statement
